{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:26:25Z","timestamp":1781177185335,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.rbmo.2020.04.007","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T20:02:51Z","timestamp":1588536171000},"page":"248-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Subcutaneous versus vaginal progesterone for vitrified\u2013warmed blastocyst transfer in artificial cycles"],"prefix":"10.1016","volume":"41","author":[{"given":"Engin","family":"Turkgeldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2322-1255","authenticated-orcid":false,"given":"Burcu Yilmaz","family":"Hanege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-7043","authenticated-orcid":false,"given":"Sule","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipek","family":"Keles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baris","family":"Ata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2020.04.007_bib0001","unstructured":"Weissman, A. Frozen-Thawed Embryo Transfer: IVF Worldwide Survey.https:\/\/ivf-worldwide.com\/survey\/frozen-thawed-embryo-transfer\/results-frozen-thawed-embryo-transfer.html"},{"key":"10.1016\/j.rbmo.2020.04.007_bib0002","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1093\/humrep\/deu194","article-title":"A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization","volume":"29","author":"Baker","year":"2014","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2020.04.007_bib0003","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4755-11-78","article-title":"Patients\u2019 administration preferences: progesterone vaginal insert [EndometrinVR] compared to intramu subcutaneous progesterone ular progesterone for luteal phase support","author":"Beltsos","year":"2014","journal-title":"Reprod. Health"},{"key":"10.1016\/j.rbmo.2020.04.007_bib0004","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/humrep\/deh316","article-title":"Acute eosinophilic pneumonia associated with intramu subcutaneous progesterone ular administration of progesterone as luteal phase support after IVF: case report","volume":"19","author":"Bouckaert","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2020.04.007_bib0005","series-title":"A.S.f.R.M., Society for Assisted Reproductive Technology 2007 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports","year":"2009"},{"key":"10.1016\/j.rbmo.2020.04.007_bib0006","series-title":"A.S.f.R.M., Society for Assisted Reproductive Technology 2016 Assisted Reproductive Technology National Summary Report","year":"2018"},{"key":"10.1016\/j.rbmo.2020.04.007_bib0007","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejogrb.2019.04.012","article-title":"Vaginal progesterone gel is non-inferior to intramu subcutaneous progesterone ular progesterone in efficacy with acceptable tolerability for luteal phase support: A prospective, randomized, multicenter study in China","volume":"237","author":"Chi","year":"2019","journal-title":"European journal of obstetrics, gynecology, and reproductive biology"},{"key":"10.1016\/j.rbmo.2020.04.007_bib0008","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.rbmo.2018.02.001","article-title":"Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles","volume":"36","author":"Child","year":"2018","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2020.04.007_bib0009","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.fertnstert.2013.05.029","article-title":"A randomized trial comparing the endometrial effects of daily subcutaneous administration of 25 mg and 50 mg progesterone in aqueous preparation","volume":"100","author":"de Ziegler","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2020.04.007_bib0010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.fertnstert.2017.11.004","article-title":"Vitrified blastocyst transfer cycles with the use of only vaginal progesterone replacement with Endometrin have inferior ongoing pregnancy rates: results from the planned interim analysis of a three-arm randomized controlled noninferiority trial","volume":"109","author":"Devine","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2020.04.007_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151388","article-title":"Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials","volume":"11","author":"Doblinger","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.rbmo.2020.04.007_bib0012","series-title":"Towards Reproductive Certainty: Infertility and Genetics Beyond","first-page":"377","article-title":"In Vitro Culture of Human Blastocyst","author":"Gardner","year":"1999"},{"key":"10.1016\/j.rbmo.2020.04.007_bib0013","article-title":"Cycle regimens for frozen-thawed embryo transfer","volume":"7","author":"Ghobara","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rbmo.2020.04.007_bib0014","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.fertnstert.2018.03.034","article-title":"Oral dydrogesterone for luteal phase support in fresh in vitro fertilization cycles: a new standard?","volume":"109","author":"Griesinger","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2020.04.007_bib0015","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/01.AOG.0000157445.67309.19","article-title":"Surrogate end points in clinical research: hazardous to your health","volume":"105","author":"Grimes","year":"2005","journal-title":"Obstetrics and gynecology"},{"key":"10.1016\/j.rbmo.2020.04.007_bib0016","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.fertnstert.2018.02.135","article-title":"Programming the endometrium for deferred transfer of cryopreserved embryos: hormone replacement versus modified natural cycles","volume":"109","author":"Groenewoud","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2020.04.007_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2013.09.010","article-title":"Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study","volume":"101","author":"Lockwood","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2020.04.007_bib0018","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.apjr.2016.10.002","article-title":"Oral dydrogesterone for luteal support in frozen-thawed embryo transfer artificial cycles: A pilot randomized controlled trial","volume":"5","author":"Rashidi","year":"2016","journal-title":"Asian Pacific Journal of Reproduction"},{"key":"10.1016\/j.rbmo.2020.04.007_bib0019","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/09513590.2012.736560","article-title":"Pharmacokinetics and safety profile of a novel progesterone aqueous formulation administered by the s.c. route","volume":"29","author":"Sator","year":"2013","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.rbmo.2020.04.007_bib0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/humupd\/6.2.139","article-title":"Comparison between different routes of progesterone administration as luteal phase support in infertility treatments","volume":"6","author":"Tavaniotou","year":"2000","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.rbmo.2020.04.007_bib0021","first-page":"49","article-title":"Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized con- trolled trial","volume":"186","author":"Tomic","year":"2015","journal-title":"Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial 2015"},{"key":"10.1016\/j.rbmo.2020.04.007_bib0022","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009154.pub3","article-title":"Luteal phase support for assisted reproduction cycles","author":"van der Linden","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rbmo.2020.04.007_bib0023","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1080\/09513590.2018.1451508","article-title":"Progesterone for preparation of the endometrium for frozen-thawed blastocyst transfer in vitro fertilization cycles: a prospective study on patients' opinions on a new subcutaneous formulation","volume":"34","author":"Venturella","year":"2018","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.rbmo.2020.04.007_bib0024","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1016\/j.fertnstert.2010.02.033","article-title":"Crinone vaginal gel is equally effective and better tolerated than intramu subcutaneous progesterone ular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study","author":"Yanushpolsky","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2020.04.007_bib0025","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s10815-016-0787-0","article-title":"Preparation of endometrium for frozen embryo replacement cycles: a systematic review and meta-analysis","volume":"33","author":"Yarali","year":"2016","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.rbmo.2020.04.007_bib0026","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00404-016-4217-4","article-title":"Comparison of four protocols for luteal phase support in frozen-thawed Embryo transfer cycles: a randomized clinical trial","volume":"295","author":"Zarei","year":"2017","journal-title":"Arch. Gynecol. Obstet."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648320301863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648320301863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:17:53Z","timestamp":1761466673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648320301863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1472648320301863"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2020.04.007","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous versus vaginal progesterone for vitrified\u2013warmed blastocyst transfer in artificial cycles","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2020.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}